ClinicalTrials.Veeva

Menu
Humber River Hospital I Clinical Research Office logo

Humber River Hospital I Clinical Research Office

Research site

Site insights

Top conditions

Top treatments

Letrozole
Tamoxifen
LY2835219
Capecitabine
Abemaciclib
Obinutuzumab
Tremelimumab
GED-0301
mFOLFIRINOX
Lidocaine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Manager, Research

Verified by this site

Active trials

8 of 50 total trials

A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (MONARCH 2)

The main purpose of this study is to compare progression-free survival for women with hormone receptor positive (HR+), human epidermal growth factor...

Active, not recruiting
Breast Neoplasms
Drug: Placebo
Drug: Fulvestrant

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Enrolling
Breast Neoplasms
Drug: Anastrozole
Drug: Tamoxifen

One of the most important obstacles to improving end-of-life care is the inability of clinicians to reliably identify those who are approaching the e...

Invitation-only
Implementation Science
Screening
Other: modified Hospital One-year Mortality Risk (mHOMR)

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor D...

Enrolling
Stage III Colon Cancer
Drug: mFOLFOX6 3-6 month
Device: Signatera test

Durvalumab is a new type of drug for many kinds of cancer. It is considered "immunotherapy" and not "chemotherapy". Laboratory tests show that it wor...

Active, not recruiting
Lung Cancer Metastatic
Drug: Platinum-Based Drug
Drug: Durvalumab

The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early s...

Active, not recruiting
Breast Cancer
Drug: Standard Adjuvant Endocrine Therapy
Drug: Abemaciclib

The goal of this clinical study is to see if sacituzumab govitecan-hziy (SG) can improve life spans of people with HR+/HER2- metastatic breast cancer...

Active, not recruiting
Locally Advanced or Unresectable Metastatic Breast Cancer
Stage IV Breast Cancer
Drug: Paclitaxel
Drug: Capecitabine

This study is an adaptive, randomized, open-label, controlled clinical trial, in collaboration with countries around the world through the World Heal...

Active, not recruiting
COVID-19
Drug: Imatinib
Drug: Artesunate

Trial sponsors

N
Roche logo
C
O
Lilly logo
University Health Network, Toronto logo
Celgene logo
National Cancer Institute (NCI) logo
T
Columbia University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems